DOXORUBICIN HYDROCHLORIDE

DOXORUBICIN HYDROCHLORIDE was reported 33034 times

DOXORUBICIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-MUELLERIAN HORMONE LEVEL DECREASED 23 0.3966
1 FOLLICULAR LYMPHOMA RECURRENT 21 0.2625
2 B-CELL LYMPHOMA REFRACTORY 23 0.2584
3 DESMOPLASTIC SMALL ROUND CELL TUMOUR 18 0.2069
4 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 164 0.1732
5 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 370 0.1676
6 MANTLE CELL LYMPHOMA RECURRENT 72 0.1655
7 HAIR DISORDER 1075 0.1303
8 NEPHROBLASTOMA 16 0.1260
9 B-CELL LYMPHOMA RECURRENT 62 0.1142
10 NAIL BED INFLAMMATION 34 0.1066
11 MENINGITIS TUBERCULOUS 53 0.0948
12 FOLLICULAR LYMPHOMA 83 0.0943
13 CENTRAL HYPOTHYROIDISM 31 0.0937
14 COLONY STIMULATING FACTOR THERAPY 19 0.0918
15 HAIR COLOUR CHANGES 1080 0.0867
16 REFRACTORY CANCER 18 0.0841
17 LYMPHOMA TRANSFORMATION 30 0.0833
18 HAIR TEXTURE ABNORMAL 1079 0.0806
19 MADAROSIS 930 0.0800
20 SMOOTH MUSCLE CELL NEOPLASM 33 0.0789
21 ACUTE MONOCYTIC LEUKAEMIA 14 0.0769
22 HEPATITIS B REACTIVATION 240 0.0755
23 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 21 0.0717
24 ACQUIRED GENE MUTATION 89 0.0679
25 ANAPLASTIC LARGE-CELL LYMPHOMA 16 0.0678
26 CENTRAL NERVOUS SYSTEM LYMPHOMA 90 0.0653
27 SARS-COV-2 TEST NEGATIVE 42 0.0622
28 ANAL INFLAMMATION 38 0.0595
29 NASAL MUCOSAL DISORDER 33 0.0566
30 ANTITHROMBIN III DECREASED 15 0.0549
31 FEBRILE NEUTROPENIA 3562 0.0536
32 DIFFUSE LARGE B-CELL LYMPHOMA 401 0.0520
33 STREPTOCOCCAL SEPSIS 56 0.0472
34 CARDIOTOXICITY 416 0.0466
35 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 15 0.0457
36 LEFT VENTRICULAR DILATATION 23 0.0450
37 METASTASES TO CHEST WALL 15 0.0432
38 CAECITIS 18 0.0400
39 NEUROBLASTOMA 15 0.0392
40 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 23 0.0388
41 METASTASES TO SPLEEN 16 0.0387
42 SECOND PRIMARY MALIGNANCY 305 0.0366
43 DILATED CARDIOMYOPATHY 37 0.0366
44 RED BLOOD CELL TRANSFUSION 15 0.0366
45 METASTASES TO BONE MARROW 18 0.0360
46 HEPATITIS B 217 0.0360
47 PSEUDOMONAL SEPSIS 63 0.0359
48 BLOOD CULTURE POSITIVE 106 0.0354
49 PSEUDOMONAL BACTERAEMIA 30 0.0351
50 PLASMA CELL MYELOMA REFRACTORY 47 0.0351
51 OVARIAN CANCER RECURRENT 54 0.0336
52 PERIPHERAL MOTOR NEUROPATHY 47 0.0335
53 FEBRILE BONE MARROW APLASIA 141 0.0331
54 CYTOMEGALOVIRUS CHORIORETINITIS 64 0.0328
55 VASOGENIC CEREBRAL OEDEMA 23 0.0319
56 MYELOID LEUKAEMIA 16 0.0319
57 NEOPLASM RECURRENCE 105 0.0309
58 RETROPERITONEAL LYMPHADENOPATHY 16 0.0304
59 MANTLE CELL LYMPHOMA 46 0.0302
60 TUMOUR LYSIS SYNDROME 264 0.0300
61 VENTRICULAR DYSFUNCTION 77 0.0296
62 KLEBSIELLA TEST POSITIVE 19 0.0292
63 MYELODYSPLASTIC SYNDROME 419 0.0289
64 NEUTROPENIC SEPSIS 205 0.0287
65 MUCOSAL INFLAMMATION 748 0.0285
66 ALVEOLITIS 40 0.0283
67 NEUTROPENIC INFECTION 26 0.0272
68 HAEMATOTOXICITY 258 0.0271
69 ACUTE MYELOID LEUKAEMIA 413 0.0265
70 COMPUTERISED TOMOGRAM THORAX ABNORMAL 18 0.0262
71 ADMINISTRATION SITE EXTRAVASATION 26 0.0260
72 CULTURE URINE POSITIVE 36 0.0256
73 PNEUMONIA KLEBSIELLA 47 0.0255
74 PLASMA CELL LEUKAEMIA 15 0.0250
75 LEFT VENTRICULAR DYSFUNCTION 167 0.0249
76 PERIPHERAL SENSORY NEUROPATHY 145 0.0248
77 SYSTOLIC DYSFUNCTION 26 0.0247
78 ENTEROVIRUS INFECTION 21 0.0243
79 GENE MUTATION 48 0.0242
80 NEUTROPENIC COLITIS 49 0.0237
81 MYELOSUPPRESSION 842 0.0234
82 DYSPLASIA 28 0.0233
83 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 15 0.0229
84 STAPHYLOCOCCAL BACTERAEMIA 99 0.0228
85 ACUTE PROMYELOCYTIC LEUKAEMIA 23 0.0224
86 OVARIAN CANCER METASTATIC 19 0.0224
87 NEUTROPHIL COUNT DECREASED 898 0.0220
88 PSEUDOMONAS TEST POSITIVE 18 0.0220
89 DEVICE RELATED THROMBOSIS 21 0.0213
90 ABDOMINAL NEOPLASM 19 0.0213
91 STREPTOCOCCAL BACTERAEMIA 23 0.0211
92 VIRAL HAEMORRHAGIC CYSTITIS 15 0.0211
93 HYPOGAMMAGLOBULINAEMIA 138 0.0210
94 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 26 0.0209
95 BLOOD BILIRUBIN ABNORMAL 26 0.0203
96 PLATELET TRANSFUSION 26 0.0202
97 BONE MARROW DISORDER 61 0.0202
98 ESCHERICHIA TEST POSITIVE 24 0.0200
99 JC VIRUS INFECTION 32 0.0200
100 GRANULOCYTE COUNT DECREASED 37 0.0199
101 PNEUMOCYSTIS JIROVECII PNEUMONIA 199 0.0198
102 CYTOPENIA 240 0.0196
103 OSTEOLYSIS 40 0.0196
104 BLOOD LACTATE DEHYDROGENASE INCREASED 307 0.0194
105 SUBCLAVIAN VEIN THROMBOSIS 22 0.0193
106 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 159 0.0193
107 HYPOFIBRINOGENAEMIA 19 0.0192
108 KLEBSIELLA BACTERAEMIA 18 0.0189
109 CYSTITIS HAEMORRHAGIC 75 0.0186
110 TROPONIN I INCREASED 31 0.0186
111 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 94 0.0184
112 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 17 0.0184
113 FUNGAL SEPSIS 15 0.0181
114 B-CELL LYMPHOMA 61 0.0179
115 CYSTITIS NONINFECTIVE 24 0.0179
116 EJECTION FRACTION DECREASED 277 0.0178
117 METASTASES TO PERITONEUM 45 0.0178
118 KLEBSIELLA SEPSIS 20 0.0177
119 CLOSTRIDIUM TEST POSITIVE 39 0.0177
120 CEREBRAL TOXOPLASMOSIS 16 0.0171
121 SYSTEMIC CANDIDA 43 0.0171
122 ACUTE LYMPHOCYTIC LEUKAEMIA 48 0.0169
123 ATELECTASIS 163 0.0169
124 PERIPHERAL SENSORIMOTOR NEUROPATHY 21 0.0167
125 NEUTROPHIL COUNT ABNORMAL 47 0.0166
126 BONE MARROW FAILURE 337 0.0166
127 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 386 0.0165
128 METASTASES TO SKIN 17 0.0165
129 VENOOCCLUSIVE LIVER DISEASE 81 0.0164
130 CARDIOMYOPATHY 242 0.0164
131 NEUTROPENIA 2223 0.0163
132 APLASIA 32 0.0163
133 ORAL INTAKE REDUCED 39 0.0161
134 CARBOHYDRATE ANTIGEN 125 INCREASED 55 0.0161
135 NEOPLASM PROGRESSION 557 0.0160
136 METASTASES TO LYMPH NODES 108 0.0160
137 PNEUMOCYSTIS JIROVECII INFECTION 19 0.0159
138 PANCYTOPENIA 889 0.0159
139 GASTROINTESTINAL TOXICITY 76 0.0158
140 JUGULAR VEIN THROMBOSIS 28 0.0157
141 CLOSTRIDIUM COLITIS 19 0.0157
142 IMMUNE-MEDIATED MYOCARDITIS 25 0.0155
143 DISEASE PROGRESSION 1812 0.0153
144 MYELOPATHY 29 0.0153
145 ESCHERICHIA SEPSIS 44 0.0152
146 OTOTOXICITY 27 0.0146
147 INTERSTITIAL LUNG DISEASE 699 0.0144
148 LYMPHOCYTOSIS 31 0.0144
149 BONE MARROW TOXICITY 17 0.0143
150 INVASIVE DUCTAL BREAST CARCINOMA 39 0.0143
151 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 37 0.0143
152 VENTRICULAR HYPOKINESIA 46 0.0143
153 TUMOUR NECROSIS 15 0.0142
154 SARCOMA 16 0.0141
155 LYMPHADENOPATHY MEDIASTINAL 27 0.0141
156 APLASTIC ANAEMIA 73 0.0140
157 CYTOKINE RELEASE SYNDROME 280 0.0139
158 MULTIPLE MYELOMA 65 0.0139
159 ISCHAEMIC HEPATITIS 19 0.0139
160 SYSTEMIC MYCOSIS 16 0.0137
161 SOFT TISSUE INFECTION 25 0.0136
162 PACKED RED BLOOD CELL TRANSFUSION 18 0.0136
163 VENOOCCLUSIVE DISEASE 34 0.0136
164 HERPES SIMPLEX 88 0.0135
165 NECROTISING COLITIS 17 0.0134
166 ACUTE HEPATIC FAILURE 183 0.0134
167 OSTEOSCLEROSIS 21 0.0133
168 LYMPHADENITIS 32 0.0132
169 STEM CELL TRANSPLANT 33 0.0132
170 SECONDARY IMMUNODEFICIENCY 16 0.0132
171 MUCOUS MEMBRANE DISORDER 18 0.0132
172 ASPARTATE AMINOTRANSFERASE ABNORMAL 20 0.0131
173 ASPERGILLUS INFECTION 86 0.0131
174 MUCORMYCOSIS 34 0.0131
175 KLEBSIELLA INFECTION 66 0.0130
176 EPSTEIN-BARR VIRUS INFECTION 81 0.0130
177 CARDIAC DYSFUNCTION 48 0.0129
178 PNEUMONIA CYTOMEGALOVIRAL 25 0.0129
179 PROCALCITONIN INCREASED 15 0.0128
180 ESCHERICHIA BACTERAEMIA 30 0.0127
181 OVARIAN CANCER 117 0.0127
182 LEUKOPENIA 634 0.0127
183 SUSPECTED OFF LABEL USE 57 0.0126
184 URETERIC OBSTRUCTION 17 0.0125
185 CYTOMEGALOVIRUS INFECTION REACTIVATION 54 0.0122
186 SEPTIC SHOCK 530 0.0122
187 PULMONARY TOXICITY 86 0.0121
188 BACTERAEMIA 144 0.0121
189 VASCULAR DEVICE INFECTION 55 0.0121
190 TROPONIN INCREASED 91 0.0119
191 STAPHYLOCOCCAL SEPSIS 59 0.0119
192 STAPHYLOCOCCUS TEST POSITIVE 25 0.0118
193 PLASMACYTOMA 22 0.0118
194 LUNG OPACITY 31 0.0118
195 B-LYMPHOCYTE COUNT DECREASED 16 0.0117
196 SMALL INTESTINAL PERFORATION 22 0.0117
197 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 87 0.0116
198 CONGESTIVE CARDIOMYOPATHY 48 0.0115
199 HYPOALBUMINAEMIA 89 0.0114
200 ILEUS PARALYTIC 51 0.0114
201 PNEUMONIA FUNGAL 45 0.0114
202 THROMBOCYTOPENIA 1270 0.0113
203 LUNG INFILTRATION 100 0.0113
204 PNEUMOCYSTIS JIROVECI PNEUMONIA 25 0.0112
205 STRONGYLOIDIASIS 18 0.0111
206 LEFT VENTRICULAR FAILURE 38 0.0110
207 LEUKOENCEPHALOPATHY 41 0.0110
208 METASTASES TO MENINGES 25 0.0110
209 AGRANULOCYTOSIS 204 0.0110
210 ENTEROCOLITIS 63 0.0109
211 BREAST CANCER METASTATIC 117 0.0109
212 PNEUMATOSIS INTESTINALIS 31 0.0109
213 THERAPY PARTIAL RESPONDER 169 0.0108
214 ENTEROCOCCAL INFECTION 52 0.0108
215 METASTASES TO SPINE 36 0.0107
216 BRONCHOPULMONARY ASPERGILLOSIS 83 0.0107
217 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 63 0.0106
218 GASTROINTESTINAL PERFORATION 44 0.0106
219 BONE LESION 38 0.0105
220 ESCHERICHIA INFECTION 86 0.0104
221 POLYNEUROPATHY 125 0.0104
222 ALANINE AMINOTRANSFERASE ABNORMAL 22 0.0104
223 DIASTOLIC DYSFUNCTION 32 0.0104
224 VENOUS THROMBOSIS 40 0.0102
225 SMALL INTESTINAL OBSTRUCTION 125 0.0101
226 HYPOPHOSPHATAEMIA 75 0.0101
227 LYMPHOMA 156 0.0101
228 CLOSTRIDIUM DIFFICILE COLITIS 107 0.0101
229 BK VIRUS INFECTION 34 0.0101
230 OESOPHAGEAL CANDIDIASIS 40 0.0100
231 ANORECTAL DISORDER 20 0.0100
232 GASTROINTESTINAL WALL THICKENING 15 0.0100
233 HYPOPROTEINAEMIA 19 0.0100
234 NEUROLOGICAL DECOMPENSATION 23 0.0099
235 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 94 0.0098
236 IMMUNE-MEDIATED ADVERSE REACTION 15 0.0098
237 CEREBRAL ISCHAEMIA 50 0.0097
238 PSEUDOMONAS INFECTION 83 0.0097
239 FUNGAEMIA 15 0.0095
240 METASTASES TO LUNG 110 0.0095
241 HAEMOGLOBIN ABNORMAL 61 0.0095
242 PARONYCHIA 41 0.0093
243 RHINOVIRUS INFECTION 36 0.0092
244 OPPORTUNISTIC INFECTION 17 0.0092
245 LOBAR PNEUMONIA 17 0.0092
246 PROCTALGIA 59 0.0092
247 PSYCHOLOGICAL TRAUMA 79 0.0091
248 SEPSIS 1012 0.0091
249 WHITE BLOOD CELL COUNT DECREASED 983 0.0091
250 VENA CAVA THROMBOSIS 15 0.0090
251 HYPERURICAEMIA 37 0.0090
252 PERFORMANCE STATUS DECREASED 42 0.0090
253 MALIGNANT NEOPLASM PROGRESSION 921 0.0090
254 NEUROPATHY PERIPHERAL 854 0.0090
255 ABDOMINAL MASS 24 0.0090
256 BACTERIAL SEPSIS 29 0.0089
257 ILEUS 110 0.0088
258 LYMPHOPENIA 125 0.0088
259 HISTIOCYTOSIS HAEMATOPHAGIC 26 0.0087
260 CHEMOTHERAPY 33 0.0087
261 RED CELL DISTRIBUTION WIDTH INCREASED 36 0.0087
262 CYTOMEGALOVIRUS INFECTION 144 0.0087
263 METASTASES TO BONE 142 0.0086
264 WHITE BLOOD CELL DISORDER 23 0.0086
265 INTESTINAL PERFORATION 96 0.0085
266 EMBOLISM 71 0.0085
267 SPINAL COLUMN INJURY 19 0.0085
268 PNEUMONITIS 230 0.0084
269 MULTIPLE ORGAN DYSFUNCTION SYNDROME 239 0.0084
270 CANDIDA INFECTION 141 0.0083
271 HYPERTRANSAMINASAEMIA 58 0.0083
272 HEPATIC LESION 36 0.0083
273 HYDRONEPHROSIS 62 0.0083
274 NEUROTOXICITY 145 0.0083
275 LYMPHOCYTE COUNT DECREASED 146 0.0083
276 STOMATITIS 499 0.0082
277 ASCITES 239 0.0081
278 ANAEMIA 1543 0.0081
279 ESCHERICHIA URINARY TRACT INFECTION 34 0.0080
280 PLEURAL EFFUSION 483 0.0079
281 LYMPHADENOPATHY 280 0.0079
282 STREPTOCOCCAL INFECTION 44 0.0079
283 BRAIN ABSCESS 20 0.0079
284 FAILURE TO THRIVE 41 0.0079
285 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 30 0.0078
286 ALOPECIA 1533 0.0078
287 FIBROSIS 24 0.0078
288 COVID-19 PNEUMONIA 92 0.0078
289 EXTRAVASATION 32 0.0078
290 SKIN TOXICITY 44 0.0078
291 OESOPHAGITIS 85 0.0078
292 CAPILLARY LEAK SYNDROME 16 0.0077
293 VARICELLA ZOSTER VIRUS INFECTION 16 0.0077
294 CYTOMEGALOVIRUS VIRAEMIA 34 0.0076
295 ACUTE RESPIRATORY DISTRESS SYNDROME 135 0.0076
296 HYPOKALAEMIA 352 0.0076
297 VARICOSE VEIN 39 0.0075
298 LUNG CONSOLIDATION 21 0.0075
299 NEPHROPATHY TOXIC 84 0.0075
300 METASTASIS 53 0.0074
301 HEPATOSPLENOMEGALY 19 0.0074
302 FOETAL GROWTH RESTRICTION 45 0.0074
303 CACHEXIA 38 0.0074
304 GASTRIC PERFORATION 20 0.0073
305 PLATELET COUNT DECREASED 772 0.0072
306 OLIGOHYDRAMNIOS 24 0.0072
307 THROMBOTIC MICROANGIOPATHY 70 0.0072
308 METASTASES TO LIVER 125 0.0071
309 CLOSTRIDIAL INFECTION 24 0.0071
310 PRODUCT USE IN UNAPPROVED INDICATION 1758 0.0071
311 CATHETER SITE ERYTHEMA 15 0.0070
312 BREAST CANCER RECURRENT 22 0.0070
313 CHRONIC LYMPHOCYTIC LEUKAEMIA 33 0.0069
314 HYPOXIA 244 0.0069
315 PLEURITIC PAIN 19 0.0069
316 PLASMA CELL MYELOMA RECURRENT 22 0.0068
317 CARDIAC FAILURE ACUTE 45 0.0067
318 METASTASES TO CENTRAL NERVOUS SYSTEM 87 0.0067
319 HYPOMAGNESAEMIA 93 0.0067
320 GRANULOCYTOPENIA 38 0.0067
321 WHITE BLOOD CELL COUNT ABNORMAL 42 0.0066
322 IMMUNOSUPPRESSION 58 0.0066
323 TRANSPLANT FAILURE 16 0.0065
324 HYPERTRIGLYCERIDAEMIA 38 0.0065
325 BRAIN NATRIURETIC PEPTIDE INCREASED 20 0.0065
326 HEART RATE ABNORMAL 36 0.0064
327 CARDIAC FAILURE CHRONIC 27 0.0063
328 DISSEMINATED INTRAVASCULAR COAGULATION 89 0.0063
329 SARCOIDOSIS 30 0.0063
330 LUNG ADENOCARCINOMA 19 0.0063
331 HYPOPHAGIA 161 0.0063
332 ORTHOPNOEA 20 0.0063
333 BACTERIAL TEST POSITIVE 14 0.0063
334 HYPERVOLAEMIA 31 0.0063
335 OESOPHAGEAL ULCER 24 0.0062
336 AMYLASE INCREASED 23 0.0062
337 HEPATIC FAILURE 187 0.0062
338 DYSAESTHESIA 19 0.0062
339 BRAIN OEDEMA 78 0.0062
340 SKIN NECROSIS 32 0.0062
341 COMPRESSION FRACTURE 33 0.0062
342 ATRIAL FLUTTER 49 0.0061
343 HYPERPYREXIA 26 0.0061
344 CARDIAC FAILURE 492 0.0061
345 NEUROLOGICAL SYMPTOM 35 0.0061
346 ENTERITIS 39 0.0061
347 ARTHRITIS BACTERIAL 25 0.0061
348 HYPERBILIRUBINAEMIA 63 0.0061
349 CATHETER SITE INFECTION 23 0.0061
350 ORAL CANDIDIASIS 80 0.0061
351 MONOCYTE COUNT INCREASED 22 0.0061
352 ACUTE PULMONARY OEDEMA 34 0.0061
353 GRAFT VERSUS HOST DISEASE 43 0.0060
354 BACTERIAL INFECTION 111 0.0059
355 LEUKAEMIA 56 0.0059
356 RESPIRATORY FAILURE 432 0.0059
357 BLOOD MAGNESIUM DECREASED 51 0.0059
358 HEPATIC CYST 20 0.0059
359 RECURRENT CANCER 24 0.0059
360 MITRAL VALVE INCOMPETENCE 66 0.0058
361 HYPOVOLAEMIA 34 0.0058
362 CATHETER SITE PAIN 15 0.0058
363 BLOOD CREATININE DECREASED 18 0.0057
364 BLOOD PHOSPHORUS DECREASED 21 0.0057
365 CANDIDIASIS 23 0.0057
366 MALNUTRITION 64 0.0057
367 DEVICE RELATED INFECTION 88 0.0057
368 PLASMA CELL MYELOMA 222 0.0057
369 RENAL TUBULAR DISORDER 16 0.0057
370 BODY TEMPERATURE INCREASED 116 0.0057
371 CARDIAC TAMPONADE 27 0.0057
372 PNEUMONIA BACTERIAL 52 0.0057
373 TACHYPNOEA 77 0.0057
374 MASS 79 0.0056
375 SINUS TACHYCARDIA 80 0.0056
376 HEPATOTOXICITY 125 0.0056
377 TUMOUR HAEMORRHAGE 16 0.0056
378 ELECTROLYTE IMBALANCE 65 0.0056
379 NEUTROPHIL COUNT INCREASED 57 0.0056
380 TRICUSPID VALVE INCOMPETENCE 44 0.0055
381 ODYNOPHAGIA 33 0.0055
382 PATHOLOGICAL FRACTURE 28 0.0055
383 PERICARDIAL EFFUSION 127 0.0055
384 LIPASE INCREASED 42 0.0055
385 BLOOD ALBUMIN DECREASED 43 0.0054
386 RESPIRATORY SYNCYTIAL VIRUS INFECTION 47 0.0054
387 NEOPLASM 62 0.0054
388 HERPES VIRUS INFECTION 31 0.0054
389 ENCEPHALITIS 37 0.0053
390 COAGULOPATHY 89 0.0053
391 DRUG RESISTANCE 137 0.0053
392 PLATELET COUNT ABNORMAL 32 0.0053
393 PYREXIA 1828 0.0053
394 HYPOCALCAEMIA 99 0.0052
395 HYPERCALCAEMIA 64 0.0052
396 UROSEPSIS 47 0.0051
397 INFUSION RELATED REACTION 336 0.0051
398 HEPATITIS FULMINANT 15 0.0051
399 ORGANISING PNEUMONIA 25 0.0050
400 SUPRAVENTRICULAR EXTRASYSTOLES 17 0.0050
401 NECROSIS 28 0.0050
402 TRANSAMINASES INCREASED 111 0.0050
403 PREMATURE LABOUR 28 0.0049
404 LYMPHOEDEMA 34 0.0049
405 PULMONARY MASS 73 0.0049
406 ENDOCARDITIS 25 0.0049
407 PORTAL HYPERTENSION 15 0.0049
408 ABDOMINAL TENDERNESS 24 0.0048
409 CARDIOGENIC SHOCK 69 0.0048
410 TUMOUR MARKER INCREASED 23 0.0048
411 ADRENAL INSUFFICIENCY 58 0.0048
412 BLOOD LACTIC ACID INCREASED 25 0.0047
413 DEEP VEIN THROMBOSIS 308 0.0047
414 PNEUMONIA VIRAL 15 0.0047
415 AORTIC VALVE INCOMPETENCE 20 0.0047
416 INFECTION 680 0.0047
417 HAEMATOCRIT DECREASED 93 0.0047
418 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 48 0.0047
419 RESPIRATORY DISTRESS 129 0.0047
420 BLOOD BILIRUBIN INCREASED 126 0.0047
421 END STAGE RENAL DISEASE 85 0.0047
422 METASTATIC NEOPLASM 20 0.0046
423 PULSE ABSENT 22 0.0046
424 SPINAL CORD COMPRESSION 18 0.0046
425 ALANINE AMINOTRANSFERASE INCREASED 282 0.0046
426 LEUKOCYTOSIS 83 0.0046
427 LUNG INFECTION 71 0.0046
428 HYPONATRAEMIA 257 0.0046
429 HAEMOGLOBIN DECREASED 466 0.0045
430 COLITIS 171 0.0045
431 BUNDLE BRANCH BLOCK LEFT 19 0.0045
432 ACUTE RESPIRATORY FAILURE 86 0.0045
433 C-REACTIVE PROTEIN INCREASED 162 0.0044
434 OFF LABEL USE 3874 0.0044
435 PLEURISY 26 0.0044
436 DISEASE RECURRENCE 207 0.0043
437 ASPARTATE AMINOTRANSFERASE INCREASED 231 0.0043
438 BLOOD CREATININE ABNORMAL 15 0.0043
439 TRANSFUSION 45 0.0043
440 THROMBOPHLEBITIS 15 0.0043
441 PULMONARY ALVEOLAR HAEMORRHAGE 24 0.0043
442 STAPHYLOCOCCAL INFECTION 141 0.0043
443 PULMONARY EMBOLISM 405 0.0043
444 THROMBOTIC THROMBOCYTOPENIC PURPURA 15 0.0043
445 NECROTISING FASCIITIS 15 0.0043
446 CARDIOMEGALY 52 0.0042
447 HYPERGLYCAEMIA 154 0.0042
448 CLOSTRIDIUM DIFFICILE INFECTION 92 0.0042
449 LEFT VENTRICULAR HYPERTROPHY 18 0.0042
450 MYOCARDITIS 48 0.0042
451 ISCHAEMIA 19 0.0041
452 METABOLIC DISORDER 24 0.0041
453 ENCEPHALOPATHY 101 0.0041
454 HAEMODYNAMIC INSTABILITY 31 0.0041
455 PATHOGEN RESISTANCE 37 0.0041
456 HEPATIC FUNCTION ABNORMAL 151 0.0040
457 HAEMORRHAGE INTRACRANIAL 60 0.0040
458 VIRAL UPPER RESPIRATORY TRACT INFECTION 19 0.0040
459 BLOOD DISORDER 32 0.0040
460 ACUTE GRAFT VERSUS HOST DISEASE 18 0.0039
461 RENAL FAILURE CHRONIC 30 0.0039
462 HAEMORRHOIDS 76 0.0039
463 HYDROCEPHALUS 21 0.0039
464 APPENDICITIS 36 0.0039
465 TACHYCARDIA 341 0.0038
466 REFUSAL OF TREATMENT BY PATIENT 25 0.0038
467 PROSTATOMEGALY 15 0.0038
468 HYPERNATRAEMIA 19 0.0038
469 PRODUCT USE ISSUE 716 0.0038
470 STRESS CARDIOMYOPATHY 22 0.0038
471 SPLENOMEGALY 44 0.0038
472 PURULENT DISCHARGE 16 0.0037
473 MENINGITIS 25 0.0037
474 IMMUNE THROMBOCYTOPENIA 17 0.0037
475 BONE PAIN 217 0.0037
476 MOUTH ULCERATION 78 0.0037
477 MONOPLEGIA 16 0.0037
478 URINE OUTPUT DECREASED 32 0.0037
479 DIVERTICULUM INTESTINAL 16 0.0037
480 SPINAL OSTEOARTHRITIS 32 0.0036
481 BLOOD URIC ACID INCREASED 21 0.0036
482 ORAL PAIN 81 0.0036
483 HEPATIC CYTOLYSIS 46 0.0036
484 BLOOD UREA INCREASED 60 0.0036
485 GASTRIC ULCER 68 0.0036
486 THERAPY NON-RESPONDER 160 0.0036
487 SUPRAVENTRICULAR TACHYCARDIA 34 0.0035
488 LUNG NEOPLASM 15 0.0035
489 PROTHROMBIN TIME PROLONGED 21 0.0035
490 AZOTAEMIA 14 0.0035
491 SKIN INFECTION 39 0.0035
492 GAMMA-GLUTAMYLTRANSFERASE INCREASED 77 0.0035
493 BLOOD CALCIUM DECREASED 39 0.0035
494 DERMATITIS BULLOUS 25 0.0035
495 BLOOD ALKALINE PHOSPHATASE INCREASED 85 0.0034
496 IMMUNODEFICIENCY 51 0.0034
497 ANOREXIA 44 0.0034
498 ORAL DISORDER 25 0.0034
499 PNEUMONIA 1103 0.0034
500 HEPATITIS 87 0.0034
501 FLUID INTAKE REDUCED 17 0.0034
502 SPINAL COMPRESSION FRACTURE 28 0.0034
503 HEPATOMEGALY 33 0.0034
504 PYELONEPHRITIS 29 0.0033
505 MENINGITIS ASEPTIC 15 0.0033
506 PANCREATITIS ACUTE 75 0.0033
507 BLOOD CREATININE INCREASED 216 0.0033
508 ATRIAL FIBRILLATION 320 0.0033
509 PNEUMOTHORAX 52 0.0033
510 ANGINA UNSTABLE 21 0.0032
511 RED BLOOD CELL COUNT DECREASED 92 0.0032
512 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 16 0.0032
513 PROTEINURIA 61 0.0032
514 FLANK PAIN 30 0.0032
515 CELLULITIS 161 0.0032
516 CHOLECYSTITIS 38 0.0032
517 HYPOTENSION 637 0.0032
518 LARGE INTESTINE PERFORATION 22 0.0032
519 ABDOMINAL ABSCESS 14 0.0032
520 FLUID OVERLOAD 46 0.0032
521 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 16 0.0032
522 ANAL ABSCESS 17 0.0032
523 RESPIRATORY RATE INCREASED 28 0.0032
524 SKIN MASS 21 0.0031
525 PULMONARY OEDEMA 140 0.0031
526 PHLEBITIS 16 0.0031
527 GUILLAIN-BARRE SYNDROME 15 0.0031
528 BENIGN PROSTATIC HYPERPLASIA 16 0.0031
529 ACCIDENT 37 0.0031
530 MENTAL STATUS CHANGES 86 0.0031
531 PREMATURE BABY 93 0.0031
532 BLOOD CALCIUM INCREASED 27 0.0031
533 SHOCK HAEMORRHAGIC 25 0.0031
534 TENDERNESS 32 0.0031
535 PULMONARY HAEMORRHAGE 24 0.0031
536 ELECTROCARDIOGRAM QT PROLONGED 109 0.0030
537 DEHYDRATION 403 0.0030
538 PHARYNGOLARYNGEAL PAIN 16 0.0030
539 CHOLECYSTITIS ACUTE 17 0.0030
540 GENERAL PHYSICAL HEALTH DETERIORATION 347 0.0030
541 GENERALISED OEDEMA 37 0.0030
542 VENTRICULAR EXTRASYSTOLES 31 0.0030
543 SQUAMOUS CELL CARCINOMA OF SKIN 18 0.0030
544 GINGIVITIS 16 0.0030
545 ORTHOSTATIC HYPOTENSION 51 0.0029
546 SPINAL PAIN 34 0.0029
547 INTENTIONAL PRODUCT USE ISSUE 254 0.0029
548 HAEMATURIA 99 0.0029
549 ACIDOSIS 22 0.0029
550 GASTROENTERITIS 42 0.0029
551 CORONAVIRUS INFECTION 19 0.0029
552 SUBDURAL HAEMATOMA 41 0.0029
553 CONSTIPATION 619 0.0028
554 ASPIRATION 31 0.0028
555 VOMITING 1329 0.0028
556 APNOEA 22 0.0028
557 DECUBITUS ULCER 23 0.0028
558 OSTEOMYELITIS 51 0.0028
559 WHITE BLOOD CELL COUNT INCREASED 108 0.0028
560 ABDOMINAL PAIN 654 0.0028
561 GASTROINTESTINAL INFLAMMATION 22 0.0028
562 UPPER GASTROINTESTINAL HAEMORRHAGE 47 0.0028
563 IMPAIRED QUALITY OF LIFE 40 0.0028
564 HERPES ZOSTER 159 0.0028
565 TOXIC EPIDERMAL NECROLYSIS 42 0.0028
566 BLOOD SODIUM DECREASED 52 0.0028
567 ACUTE MYOCARDIAL INFARCTION 81 0.0027
568 OSTEONECROSIS 90 0.0027
569 SHOCK 63 0.0027
570 ACUTE KIDNEY INJURY 416 0.0027
571 GASTROINTESTINAL DISORDER 242 0.0027
572 FACIAL PARALYSIS 23 0.0027
573 HEPATIC STEATOSIS 50 0.0027
574 HIP ARTHROPLASTY 41 0.0027
575 DIARRHOEA HAEMORRHAGIC 25 0.0027
576 MULTI-ORGAN FAILURE 46 0.0027
577 INTESTINAL OBSTRUCTION 100 0.0027
578 BONE DISORDER 48 0.0026
579 DRUG-INDUCED LIVER INJURY 82 0.0026
580 HEPATOCELLULAR INJURY 37 0.0026
581 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 142 0.0026
582 FUNGAL INFECTION 86 0.0026
583 RESPIRATORY TRACT INFECTION 67 0.0026
584 INFUSION SITE EXTRAVASATION 16 0.0026
585 LOWER GASTROINTESTINAL HAEMORRHAGE 19 0.0026
586 RENAL FAILURE ACUTE 109 0.0026
587 NERVOUS SYSTEM DISORDER 80 0.0026
588 ATRIOVENTRICULAR BLOCK COMPLETE 17 0.0025
589 DIVERTICULUM 18 0.0025
590 JAUNDICE 68 0.0025
591 SKIN ULCER 65 0.0025
592 CHILLS 294 0.0025
593 PULMONARY FIBROSIS 48 0.0025
594 TOXICITY TO VARIOUS AGENTS 421 0.0025
595 POST PROCEDURAL HAEMORRHAGE 29 0.0025
596 RHINITIS 20 0.0025
597 DECREASED APPETITE 576 0.0025
598 RASH MACULO-PAPULAR 55 0.0025
599 HIATUS HERNIA 32 0.0025
600 CONCOMITANT DISEASE AGGRAVATED 15 0.0024
601 PULMONARY CONGESTION 32 0.0024
602 OSTEONECROSIS OF JAW 60 0.0024
603 CYANOSIS 38 0.0024
604 DUODENAL ULCER 17 0.0024
605 SKIN LESION 66 0.0024
606 UNRESPONSIVE TO STIMULI 62 0.0024
607 DIALYSIS 34 0.0024
608 CHOLESTASIS 46 0.0024
609 BRAIN INJURY 24 0.0024
610 MYOCARDIAL ISCHAEMIA 27 0.0024
611 PULMONARY HYPERTENSION 49 0.0024
612 HYPOTHYROIDISM 75 0.0023
613 HAEMOLYTIC ANAEMIA 21 0.0023
614 GASTROINTESTINAL INFECTION 21 0.0023
615 CEREBRAL INFARCTION 57 0.0023
616 GASTRITIS 61 0.0023
617 ISCHAEMIC STROKE 41 0.0023
618 GLOMERULAR FILTRATION RATE DECREASED 28 0.0023
619 RESPIRATORY DISORDER 68 0.0023
620 CARDIAC FAILURE CONGESTIVE 182 0.0023
621 COVID-19 396 0.0023
622 ABSCESS 36 0.0023
623 VENTRICULAR FIBRILLATION 25 0.0022
624 UPPER RESPIRATORY TRACT INFECTION 104 0.0022
625 HEPATIC ENCEPHALOPATHY 21 0.0022
626 RENAL IMPAIRMENT 189 0.0022
627 DELIRIUM 78 0.0022
628 BLOOD POTASSIUM DECREASED 67 0.0022
629 DYSPHAGIA 210 0.0022
630 DRUG TOXICITY 30 0.0022
631 HICCUPS 18 0.0022
632 LUNG DISORDER 107 0.0022
633 DYSPNOEA EXERTIONAL 82 0.0022
634 BLOOD PRESSURE DIASTOLIC DECREASED 16 0.0022
635 PNEUMONIA ASPIRATION 54 0.0022
636 DERMATITIS 45 0.0021
637 RENAL CYST 17 0.0021
638 SYNCOPE 214 0.0021
639 ULCER 34 0.0021
640 SQUAMOUS CELL CARCINOMA 20 0.0021
641 WEIGHT FLUCTUATION 22 0.0021
642 PHARYNGITIS 26 0.0021
643 ASTHENIA 787 0.0021
644 DRUG ERUPTION 37 0.0021
645 NAUSEA 1652 0.0021
646 GASTRIC HAEMORRHAGE 24 0.0021
647 TOXIC SKIN ERUPTION 21 0.0021
648 RENAL FAILURE 275 0.0021
649 TOOTH ABSCESS 21 0.0021
650 SUBARACHNOID HAEMORRHAGE 21 0.0021
651 CARDIAC ARREST 170 0.0021
652 VENTRICULAR TACHYCARDIA 34 0.0021
653 ACUTE CORONARY SYNDROME 17 0.0021
654 SKIN FISSURES 40 0.0020
655 OXYGEN SATURATION DECREASED 113 0.0020
656 ARRHYTHMIA 95 0.0020
657 MELAENA 44 0.0020
658 BLOOD TEST ABNORMAL 28 0.0020
659 OEDEMA 107 0.0020
660 SINUS BRADYCARDIA 19 0.0020
661 HYPERTHERMIA 15 0.0020
662 FISTULA 22 0.0020
663 STATUS EPILEPTICUS 22 0.0019
664 BACK PAIN 452 0.0019
665 NAIL DISORDER 17 0.0019
666 ANAPHYLACTIC SHOCK 50 0.0019
667 MUSCULOSKELETAL CHEST PAIN 30 0.0019
668 ATAXIA 23 0.0019
669 HYPERTHYROIDISM 28 0.0019
670 HAEMATEMESIS 49 0.0019
671 SENSORY DISTURBANCE 31 0.0019
672 TUBULOINTERSTITIAL NEPHRITIS 36 0.0019
673 TORSADE DE POINTES 15 0.0019
674 HEPATITIS C 23 0.0019
675 SUDDEN DEATH 20 0.0019
676 ANAL INCONTINENCE 17 0.0019
677 SKIN HYPERPIGMENTATION 16 0.0019
678 LIVER DISORDER 82 0.0018
679 LIVER INJURY 45 0.0018
680 GROIN PAIN 16 0.0018
681 PREMATURE DELIVERY 29 0.0018
682 GASTROINTESTINAL HAEMORRHAGE 152 0.0018
683 PURPURA 16 0.0018
684 DIARRHOEA 1156 0.0018
685 DEAFNESS 46 0.0018
686 OBESITY 28 0.0018
687 OEDEMA PERIPHERAL 214 0.0018
688 THROMBOSIS 140 0.0017
689 NIGHT SWEATS 56 0.0017
690 PAIN IN JAW 49 0.0017
691 TOOTH FRACTURE 19 0.0017
692 ERYTHEMA MULTIFORME 16 0.0017
693 DYSURIA 63 0.0017
694 ARTERIOSCLEROSIS 16 0.0017
695 PALLOR 46 0.0017
696 PERITONITIS 35 0.0017
697 BREAST PAIN 18 0.0017
698 HYPERKALAEMIA 59 0.0017
699 BRADYCARDIA 89 0.0017
700 MYOSITIS 15 0.0017
701 HYPERTENSION 354 0.0017
702 HEMIPARESIS 28 0.0017
703 RESTLESSNESS 60 0.0016
704 RENAL TUBULAR NECROSIS 16 0.0016
705 PETECHIAE 17 0.0016
706 DENTAL CARIES 18 0.0016
707 PANCREATITIS 86 0.0016
708 CARDIO-RESPIRATORY ARREST 68 0.0016
709 BODY TEMPERATURE DECREASED 16 0.0016
710 INTERVERTEBRAL DISC DEGENERATION 15 0.0016
711 FOLLICULITIS 17 0.0016
712 CEREBRAL HAEMORRHAGE 58 0.0016
713 DYSPNOEA 915 0.0016
714 CARDIAC DISORDER 150 0.0016
715 CENTRAL NERVOUS SYSTEM LESION 22 0.0016
716 PRODUCTIVE COUGH 75 0.0016
717 METABOLIC ACIDOSIS 50 0.0016
718 NEURALGIA 38 0.0016
719 VIRAL INFECTION 52 0.0016
720 SKIN DISORDER 52 0.0016
721 WOUND INFECTION 17 0.0016
722 BASAL CELL CARCINOMA 24 0.0015
723 GINGIVAL BLEEDING 21 0.0015
724 ORAL HERPES 30 0.0015
725 PLATELET COUNT INCREASED 20 0.0015
726 TOOTH EXTRACTION 19 0.0015
727 DEPRESSED LEVEL OF CONSCIOUSNESS 60 0.0015
728 HYPOKINESIA 22 0.0015
729 GENERALISED TONIC-CLONIC SEIZURE 25 0.0015
730 CONJUNCTIVITIS 28 0.0015
731 INTERNATIONAL NORMALISED RATIO INCREASED 43 0.0015
732 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 107 0.0015
733 PERICARDITIS 25 0.0015
734 PERITONITIS BACTERIAL 15 0.0015
735 HYPOTHERMIA 15 0.0015
736 SEIZURE 171 0.0015
737 EXPOSURE DURING PREGNANCY 92 0.0015
738 NO THERAPEUTIC RESPONSE 18 0.0015
739 MUSCLE TWITCHING 34 0.0015
740 BRONCHOSPASM 21 0.0015
741 EPISTAXIS 110 0.0015
742 BLISTER 82 0.0015
743 INCORRECT ROUTE OF DRUG ADMINISTRATION 52 0.0015
744 BLOOD PRESSURE DECREASED 96 0.0014
745 CYSTITIS 46 0.0014
746 LIVER FUNCTION TEST ABNORMAL 42 0.0014
747 DRUG INTOLERANCE 139 0.0014
748 PELVIC PAIN 26 0.0014
749 BLOOD POTASSIUM INCREASED 23 0.0014
750 URINARY TRACT INFECTION 240 0.0014
751 CONDITION AGGRAVATED 427 0.0014
752 OROPHARYNGEAL PAIN 130 0.0014
753 ADVERSE EVENT 129 0.0014
754 LIVER FUNCTION TEST INCREASED 30 0.0014
755 PARALYSIS 20 0.0014
756 ANGINA PECTORIS 40 0.0014
757 FATIGUE 1084 0.0014
758 CONFUSIONAL STATE 225 0.0014
759 FULL BLOOD COUNT DECREASED 28 0.0014
760 URINARY RETENTION 46 0.0014
761 COUGH 386 0.0014
762 APHASIA 41 0.0014
763 PRESYNCOPE 33 0.0014
764 ABDOMINAL PAIN LOWER 34 0.0013
765 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 23 0.0013
766 CARDIOVASCULAR DISORDER 34 0.0013
767 HYPERLIPIDAEMIA 16 0.0013
768 DIVERTICULITIS 37 0.0013
769 RECTAL HAEMORRHAGE 57 0.0013
770 TOOTHACHE 24 0.0013
771 CHEST DISCOMFORT 135 0.0013
772 DIPLOPIA 34 0.0013
773 HYPERSENSITIVITY 243 0.0013
774 TOOTH INFECTION 17 0.0013
775 OSTEOPOROSIS 53 0.0013
776 WEIGHT DECREASED 358 0.0013
777 INTERVERTEBRAL DISC PROTRUSION 28 0.0013
778 SKIN REACTION 18 0.0013
779 EATING DISORDER 27 0.0013
780 TREATMENT FAILURE 104 0.0013
781 HAEMOPTYSIS 35 0.0013
782 ERYTHEMA 256 0.0012
783 CIRCULATORY COLLAPSE 21 0.0012
784 CHEST PAIN 228 0.0012
785 GOUT 22 0.0012
786 DEATH 1055 0.0012
787 PARANOIA 21 0.0012
788 RIB FRACTURE 25 0.0012
789 RASH ERYTHEMATOUS 58 0.0012
790 SARS-COV-2 TEST POSITIVE 16 0.0012
791 FLUSHING 122 0.0012
792 LETHARGY 69 0.0012
793 OSTEOPENIA 18 0.0012
794 URINARY INCONTINENCE 35 0.0012
795 BLOOD PRESSURE SYSTOLIC INCREASED 23 0.0012
796 COMA 56 0.0012
797 STEVENS-JOHNSON SYNDROME 26 0.0012
798 MUSCULAR WEAKNESS 132 0.0012
799 HEPATIC ENZYME INCREASED 79 0.0012
800 DYSPEPSIA 114 0.0012
801 IMPAIRED HEALING 38 0.0012
802 FOETAL EXPOSURE DURING PREGNANCY 94 0.0012
803 ILL-DEFINED DISORDER 69 0.0011
804 EAR PAIN 22 0.0011
805 MUSCULOSKELETAL PAIN 59 0.0011
806 ANAPHYLACTIC REACTION 62 0.0011
807 INFLAMMATION 57 0.0011
808 SPINAL FRACTURE 22 0.0011
809 DEPRESSION 249 0.0011
810 POST PROCEDURAL COMPLICATION 21 0.0011
811 ABDOMINAL DISTENSION 114 0.0011
812 BLINDNESS 44 0.0011
813 CHROMATURIA 24 0.0011
814 ALTERED STATE OF CONSCIOUSNESS 23 0.0011
815 DISORIENTATION 42 0.0011
816 MATERNAL EXPOSURE DURING PREGNANCY 94 0.0011
817 SKIN DISCOLOURATION 48 0.0010
818 THERAPEUTIC PRODUCT EFFECT DECREASED 46 0.0010
819 AMENORRHOEA 18 0.0010
820 PARAESTHESIA 160 0.0010
821 MYALGIA 172 0.0010
822 CHOLELITHIASIS 33 0.0010
823 THERAPEUTIC RESPONSE DECREASED 60 0.0010
824 LACTIC ACIDOSIS 32 0.0010
825 HAEMATOCHEZIA 54 0.0010
826 HYPOAESTHESIA 146 0.0010
827 LOCAL SWELLING 17 0.0010
828 COGNITIVE DISORDER 45 0.0010
829 RASH 418 0.0010
830 DRUG INTERACTION 152 0.0010
831 CORONARY ARTERY DISEASE 29 0.0010
832 DIABETIC KETOACIDOSIS 23 0.0010
833 INFLUENZA 105 0.0009
834 SKIN EXFOLIATION 79 0.0009
835 POLLAKIURIA 39 0.0009
836 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 24 0.0009
837 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 48 0.0009
838 ECZEMA 48 0.0009
839 TOOTH LOSS 19 0.0009
840 HEART RATE INCREASED 90 0.0009
841 PAIN 557 0.0009
842 DRUG LEVEL INCREASED 15 0.0009
843 MALAISE 389 0.0009
844 LABORATORY TEST ABNORMAL 26 0.0009
845 HAEMORRHAGE 92 0.0009
846 ADVERSE DRUG REACTION 79 0.0009
847 DYSARTHRIA 33 0.0009
848 SCAR 15 0.0009
849 ANXIETY 246 0.0009
850 OSTEOARTHRITIS 36 0.0008
851 BLOOD TRIGLYCERIDES INCREASED 15 0.0008
852 NECK PAIN 47 0.0008
853 BREAST CANCER 78 0.0008
854 LUNG NEOPLASM MALIGNANT 34 0.0008
855 RHINORRHOEA 53 0.0008
856 EPILEPSY 25 0.0008
857 LOWER RESPIRATORY TRACT INFECTION 37 0.0008
858 THROAT TIGHTNESS 22 0.0008
859 LOSS OF CONSCIOUSNESS 104 0.0008
860 FLATULENCE 46 0.0008
861 HAEMATOMA 21 0.0008
862 GASTROOESOPHAGEAL REFLUX DISEASE 65 0.0008
863 CHRONIC KIDNEY DISEASE 61 0.0008
864 HYPERHIDROSIS 103 0.0008
865 NEOPLASM MALIGNANT 53 0.0008
866 TASTE DISORDER 16 0.0008
867 MUSCULOSKELETAL DISORDER 15 0.0008
868 CONVULSION 45 0.0008
869 SPEECH DISORDER 41 0.0008
870 EMOTIONAL DISTRESS 94 0.0008
871 DRUG INEFFECTIVE 1016 0.0008
872 TINNITUS 35 0.0008
873 PALPITATIONS 89 0.0008
874 MENTAL DISORDER 33 0.0008
875 PAIN IN EXTREMITY 219 0.0007
876 FEEDING DISORDER 15 0.0007
877 FAECES DISCOLOURED 16 0.0007
878 PRODUCT PREPARATION ERROR 15 0.0007
879 RENAL DISORDER 34 0.0007
880 DYSSTASIA 21 0.0007
881 GLOSSODYNIA 16 0.0007
882 LOCALISED INFECTION 17 0.0007
883 FEELING HOT 43 0.0007
884 RASH PRURITIC 38 0.0007
885 RASH GENERALISED 18 0.0007
886 DISCOMFORT 42 0.0007
887 SINUSITIS 70 0.0007
888 DIZZINESS 338 0.0007
889 BRONCHITIS 50 0.0007
890 RHABDOMYOLYSIS 28 0.0007
891 HEADACHE 417 0.0007
892 TREATMENT NONCOMPLIANCE 36 0.0007
893 INFLUENZA LIKE ILLNESS 54 0.0007
894 FEELING COLD 18 0.0006
895 FEMUR FRACTURE 20 0.0006
896 WOUND 18 0.0006
897 HYPOGLYCAEMIA 31 0.0006
898 SWELLING 59 0.0006
899 TRANSIENT ISCHAEMIC ATTACK 21 0.0006
900 MYOCARDIAL INFARCTION 108 0.0006
901 RESPIRATORY ARREST 17 0.0006
902 FALL 201 0.0006
903 ABDOMINAL DISCOMFORT 101 0.0006
904 LACRIMATION INCREASED 18 0.0006
905 PAIN OF SKIN 16 0.0006
906 TYPE 2 DIABETES MELLITUS 20 0.0006
907 ARTHROPATHY 33 0.0006
908 HIP FRACTURE 19 0.0006
909 HOT FLUSH 44 0.0006
910 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
911 ABDOMINAL PAIN UPPER 119 0.0006
912 RENAL INJURY 17 0.0006
913 BLOOD PRESSURE INCREASED 87 0.0006
914 DEPRESSED MOOD 30 0.0006
915 INSOMNIA 149 0.0006
916 ARTHRALGIA 232 0.0006
917 SWELLING FACE 36 0.0006
918 DYSPHONIA 32 0.0005
919 DIABETES MELLITUS 41 0.0005
920 AGITATION 39 0.0005
921 SLEEP DISORDER 37 0.0005
922 MEDICATION ERROR 29 0.0005
923 AGGRESSION 26 0.0005
924 VISUAL ACUITY REDUCED 17 0.0005
925 HYPOACUSIS 22 0.0005
926 OESOPHAGEAL CARCINOMA 15 0.0005
927 DYSGEUSIA 37 0.0005
928 GAIT DISTURBANCE 94 0.0005
929 EYE DISORDER 16 0.0005
930 ARTHRITIS 38 0.0005
931 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 23 0.0005
932 MOBILITY DECREASED 34 0.0005
933 OCULAR HYPERAEMIA 22 0.0005
934 DISTURBANCE IN ATTENTION 25 0.0005
935 SOMNOLENCE 93 0.0005
936 BLOOD GLUCOSE INCREASED 86 0.0005
937 VISION BLURRED 61 0.0004
938 BALANCE DISORDER 38 0.0004
939 UNDERDOSE 31 0.0004
940 TREMOR 69 0.0004
941 INJURY 29 0.0004
942 NASAL CONGESTION 24 0.0004
943 ILLNESS 42 0.0004
944 DRY MOUTH 33 0.0004
945 DRY EYE 20 0.0004
946 BLOOD GLUCOSE DECREASED 19 0.0004
947 VERTIGO 24 0.0004
948 PRURITUS 150 0.0004
949 THERAPY CESSATION 20 0.0004
950 WHEEZING 23 0.0004
951 AMNESIA 25 0.0004
952 DRY SKIN 51 0.0004
953 URTICARIA 63 0.0004
954 CONTUSION 36 0.0004
955 MEMORY IMPAIRMENT 51 0.0004
956 VAGINAL HAEMORRHAGE 16 0.0004
957 NASOPHARYNGITIS 67 0.0004
958 HALLUCINATION 27 0.0004
959 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
960 BURNING SENSATION 25 0.0004
961 PERIPHERAL SWELLING 54 0.0004
962 THERAPY INTERRUPTED 25 0.0003
963 NEPHROLITHIASIS 16 0.0003
964 CEREBROVASCULAR ACCIDENT 59 0.0003
965 HOSPITALISATION 53 0.0003
966 WEIGHT INCREASED 76 0.0003
967 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 60 0.0003
968 NO ADVERSE EVENT 59 0.0003
969 ANGIOEDEMA 14 0.0003
970 FLUID RETENTION 16 0.0003
971 MIGRAINE 28 0.0003
972 VISUAL IMPAIRMENT 36 0.0003
973 ASTHMA 31 0.0003
974 CATARACT 16 0.0003
975 FEELING ABNORMAL 64 0.0003
976 MUSCLE SPASMS 48 0.0003
977 SUICIDAL IDEATION 23 0.0003
978 DRUG DOSE OMISSION 39 0.0002
979 UNEVALUABLE EVENT 16 0.0002
980 MUSCULOSKELETAL STIFFNESS 18 0.0002
981 OVERDOSE 43 0.0002
982 PROSTATE CANCER 15 0.0002
983 PRODUCT QUALITY ISSUE 22 0.0002
984 JOINT SWELLING 18 0.0001
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 23 0.0001
986 INCORRECT DOSE ADMINISTERED 23 0.0001
987 PRODUCT DOSE OMISSION ISSUE 16 0.0001